We are a global, high-growth diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. Our proprietary T-SPOT® technology platform allows us to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. T cells are a central component of the human body’s immune system, and are implicated in the control and progression of many medical conditions, including certain types of infectious diseases, cancers and autoimmune diseases.
This section of our website offers a significant amount of information for the investor community. If you have questions or comments after reviewing the information provided here, our Investor Relations department may be reached through the "Contact Us" tab.
Copyright Nasdaq. Minimum 15 minutes delayed.
Events & Presentations
Jan 11, 2018 2:00 PM EST
Oxford Immunotec to Present at the 36th Annual J.P. Morgan Healthcare Conference
Nov 28, 2017 12:00 PM EST
Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference